Gilles Lavigne: Pain as a trigger of poor sleep quality, a cause of insomnia, and a disrupter of sleep apnea

Pain is not only a symptom but also a powerful disruptor of sleep. In this lecture, Dr. Gilles Lavigne will explore how pain impacts sleep quality, contributes to insomnia, and interacts with obstructive sleep apnea. The session will provide an accessible overview of underlying mechanisms, clinical implications, and management strategies—both pharmacological and non-pharmacological. Surgeons will gain valuable insights into recognizing and addressing pain–sleep interactions that influence patient outcomes.

SPEAKER:

Dr. Gilles Lavigne, DMD, PhD, CM, is a leading clinician-scientist in orofacial pain and dental sleep medicine. His research has transformed understanding of how pain and sleep interact, particularly in conditions such as bruxism, insomnia, and obstructive sleep apnea. Former Dean of Dentistry at Université de Montréal and past President of the Canadian Sleep and Pain Societies, he held a Canada Research Chair in Pain, Sleep & Trauma. A Member of the Order of Canada and Fellow of the Canadian Academy of Health Sciences, Dr. Lavigne now serves as Professor at McGill University.

LEARNING OBJECTIVES:

After attending this session, participants will be able to:

1. Describe the mechanisms linking pain with disrupted sleep, insomnia, and obstructive sleep apnea.

2. Recognize the clinical impact of pain–sleep interactions on patient outcomes.

3. Identify pharmacological and non-pharmacological strategies for managing pain-related sleep disturbances.

4. Integrate principles of dental sleep medicine and pain management into surgical and clinical decision-making.

TARGET AUDIENCE:

This session is designed for surgeons, oral and maxillofacial specialists, dentists, sleep physicians, and other healthcare professionals involved in managing patients with pain, sleep disorders, or sleep-related breathing disturbances.

ONLINE LIVE EVENT ( Free of Charge )

San Francisco: Monday, March 23, 2026 at 3:00 pm

Mexico City: Monday, March 23, 2026 at 4:00 pm

New York: Monday, March 23, 2026 at 6:00 pm

Rio de Janeiro: Monday, March 23, 2026 at 7:00 pm

London: Monday, March 23, 2026 at 10:00 pm

Berlin: Monday, March 23, 2026 at 11:00 pm

Johannesburg: Tuesday, March 24, 2026 at 12:00 midnight

Cairo: Tuesday, March 24, 2026 at 12:00 midnight

Dubai: Tuesday, March 24, 2026 at 2:00 am

Delhi: Tuesday, March 24, 2026 at 3:30 am

Manila: Tuesday, March 24, 2026 at 6:00 am

Sydney: Tuesday, March 24, 2026 at 9:00 am

CME ACCREDITATION: This event may be accredited by the European Accreditation Council for Continuing Medical Education (EACCME®) for a maximum of 1 European CME credits (ECMEC®s). Each medical specialist should claim only those hours of credit that he/she actually spent in the educational activity. If you are a learner based in the U.S. or Canada EACCME credits are recognized by the American Medical Association (AMA) and the Royal College of Physicians and Surgeons of Canada.

LANGUAGE: The event language is english. 

DECLARATION: In accordance with criterion 13 of document UEMS 2023.07.rev “EACCME® Criteria for the Accreditation of Live Educational Events (LEEs)” and the Standard v. Commercial or Promotional Conflict of Interest, published by the American Dental Association Continuing Education Recognition Program (ADA CERP), all surgeON presenters sign a Conflict of Interest form to document all perceived or actual conflicts of interest for the last 3 years, whether due to a financial or other relationship. This document can be viewed at the beginning of the event or on request by emailing info@surgeon-events.org No fee, honorarium or arrangement for re-imbursement of expenses in relation to the this event has been provided to the speaker.